Company Number: 15538085

Analysis Date: 2025-07-19 11:51 UTC

1. Risk Rating: HIGH
   Justification: The company is newly incorporated (March 2024) and has filed only its first set of unaudited micro-entity accounts for the period ending March 2025. The financial statements provided show no capital or reserves figures disclosed, no detailed assets or liabilities reported, and only one employee. Such limited financial data, combined with the lack of operational history, indicates a high risk from a solvency and liquidity perspective due to insufficient evidence of financial stability or cash flow.

2. Key Concerns:

• Absence of detailed financial data: The accounts do not present assets, liabilities, or equity details, preventing assessment of net asset position or working capital.
• Early-stage operational risk: Being less than two years old with minimal staff and no audit reduces visibility into operational sustainability or revenue generation.
• Concentration of control: Both directors are also persons with significant control, each holding 25-50% shares and voting rights, which may pose governance risks if disputes arise.

3. Positive Indicators:

• Compliance with filing deadlines: The company has filed its accounts and confirmation statements on time, indicating regulatory compliance and governance awareness.
• Clear PSC disclosure: Transparency around persons with significant control is in place, facilitating ownership scrutiny.
• Industry classification: Operating in general medical practice and health regulation sectors, which can be stable industries if well managed.

4. Due Diligence Notes:

• Obtain the detailed financial statements including balance sheet, profit and loss, and cash flow data to assess solvency and liquidity.
• Review business model, contracts, or revenue streams to evaluate operational viability and sustainability.
• Investigate any related party transactions or director loans given the ownership concentration.
• Monitor future filings to track financial progress and compliance continuity.
• Confirm any external financing arrangements, guarantees, or contingent liabilities.